Dementia associated with the acquired immunodeficiency syndrome

New England Journal of Medicine

Volumn 332, Issue 14, 1995, Pages 934-940

  Flier, Jeffrey S ^a   Underhill, Lisa H ^a   Lipton, Stuart A ^b   Gendelman, Howard E ^c  

^a Harvard Medical School ^*

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; NITRIC OXIDE; ARACHIDONIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CD4 ANTIGEN; CYSTEINE; DIDANOSINE; GAMMA INTERFERON; GLUTAMIC ACID; GLYCERYL TRINITRATE; GLYCINE; HYDROXYL RADICAL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN; NIMODIPINE; PEROXIDE; QUINOLINIC ACID; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN; HUMAN; MACROPHAGE; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS REPLICATION; ASTROCYTE; BRAIN INJURY; BRAIN NERVE CELL; CLINICAL TRIAL; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROGLIA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

AIDS DEMENTIA COMPLEX; BRAIN; HIV ENVELOPE PROTEIN GP120; HUMAN; MACROPHAGES; NEURONS; NITRIC OXIDE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS REPLICATION;

EID: 0028909868     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199504063321407     Document Type: Review

References (75)

1. Bacellar H, Munoz A, Miller EN, Temporal trends in the incidence of HIV-1-related neurologic diseases.: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994; 44.: 1892-1900
2. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P The brain and AIDS.: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239.: 586-592
3. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991; 1.: 163-175
4. Ketzler S, Weis S, Haug H, Budka H Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 1990; 80.: 92-94
5. Everall IP, Luthert PJ, Lantos PL Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337.: 1119-1121
6. Wiley CA, Masliah E, Morey M, Neocortical damage during HIV infection. Ann Neurol 1991; 29.: 651-657
7. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992; 32.: 321-329
8. Tenhula WN, Xu SZ, Madigan MC, Heller K, Freeman WR, Sadun AA Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol 1992; 113.: 14-20
9. Seilhean D, Duyckaerts C, Vazeux R, HIV-1-associated cognitive/motor complex.: absence of neuronal loss in the cerebral neocortex. Neurology 1993; 43.: 1492-1499
10. Koenig S, Gendelman HE, Orenstein JM, Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233.: 1089-1093
11. Saito T, Sharer LR, Epstein LG, Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44.: 474-481
12. Tornatore C, Chandra R, Berger JR, Major EO HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44.: 481-487
13. Brenneman DE, Westbrook GL, Fitzgerald SP, Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988; 335.: 639-642
14. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990; 248.: 364-367
15. Dreyer EB, Lipton SA Toxic neuronal effects of the HIV coat protein gp120 may be mediated through macrophage arachidonic acid. Soc Neurosci 1994; 20.: 1049-1049 abstract.
16. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A 1989; 86.: 621-625
17. Hayman M, Arbuthnott G, Harkiss G, Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 1993; 53.: 1-6
18. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994; 367.: 188-193
19. Yeh MW, Nottet HLM, Gendelman HE, Lipton SA HIV-1 coat protein gp120 stimulates human macrophages to release L-cysteine, and NMDA agonist. Soc Neurosci 1994; 20.: 451-451 abstract.
20. Heyes MP, Brew BJ, Martin A, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection.: relationship to clinical and neurological status. Ann Neurol 1991; 29.: 202-209
21. Genis P, Jett M, Bernton EW, Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions.: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176.: 1703-1718
22. Lipton SA, Rosenberg PA Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330.: 613-622
23. Gelbard HA, Nottet HSLM, Swindells S, Platelet-activating factor.: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994; 68.: 4628-4635
24. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Regulation of nitric oxide synthase activity in HIV-1 infected monocytes.: implications for HIV-associated neurological disease. J Exp Med 1995; 181.: 735-745
25. Lo TM, Fallert CJ, Piser TM, Thayer SA HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res 1992; 594.: 189-196
26. Lipton S.A. Models of neuronal injury in AIDS.: another role for the NMDA receptor. Trends Neurosci 1992; 15.: 75-79
27. Tyor WR, Glass JD, Griffin JW, Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992; 31.: 349-360
28. Wesselingh SL, Power C, Glass JD, Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993; 33.: 576-582
29. Griffin DE, Wesselingh SL, McArthur JC Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994; 35.: 592-597
30. Giulian D, Vaca K, Noonan CA Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250.: 1593-1596
31. Pulliam L, Herndier BG, Tang NM, McGrath MS Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 1991; 87.: 503-512
32. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF Proliferations of astrocytes in vitro in response to cytokines.: a primary role for tumor necrosis factor. J Immunol 1990; 144.: 129-135
33. Valone FH, Epstein LB Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1β, tumor necrosis factor, or IFN-γ. J Immunol 1988; 141.: 3945-3950
34. Heyes MP, Saito K, Markey SP Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J 1992; 283.: 633-635
35. Soliven B, Albert J Tumor necrosis factor modulates Ca+ currents in cultured sympathetic neurons. J Neurosci 1992; 12.: 2665-2671
36. Simmons ML, Murphy S Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 1993; 5.: 825-831
37. Lipton SA, Kaiser PK, Sucher NJ, Dreyer EB, Offermann JT AIDS virus coat protein sensitizes neurons to NMDA receptor-mediated toxicity. Soc Neurosci 1990; 16.: 289-289 abstract.
38. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991; 7.: 111-118
39. Lipton S.A. Calcium channel antagonists in the prevention of neurotoxicity. Adv Pharmacol 1991; 22.: 271-297
40. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HSLM The neuropathogenesis of HIV-1 infection. J Leukoc Biol 1994; 56.: 389-398
41. Griffin DE, McArthur JC, Cornblath DR Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 1991; 41.: 69-74
42. McArthur JC, Nance-Sproson TE, Griffin DE, The diagnostic utility of elevation in cerebrospinal fluid β2-microglobulin in HIV-1 dementia.: Multicenter AIDS Cohort Study. Neurology 1992; 42.: 1707-1712
43. Griffin DE, Wesselingh SL, McArthur JC Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994; 35.: 592-597
44. Nottet SLM, Jett M, Flanagan CR, et al. A regulatory role for astrocytes in HIV-1 encephalitis.: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol (in press).
45. Volterra A, Trotti D, Cassutti P, High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem 1992; 59.: 600-606
46. Miller B, Sarantis M, Traynelis SF, Attwell D Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355.: 722-725
47. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 1991; 88.: 6368-6371
48. Dawson VL, Dawson TM, Uhl GR, Snyder SH Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A 1993; 90.: 3256-3259
49. Lipton SA, Choi YB, Pan ZH, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364.: 626-632
50. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J NMDA-dependent superoxide production and neurotoxicity. Nature 1993; 364.: 535-537
51. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA Apparent hydroxyl radical production by peroxynitrite.: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87.: 1620-1624
52. Lipton S.A. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 1992; 3.: 913-915
53. Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro GM, Nistico G HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun 1993; 194.: 439-445
54. Hewett SJ, Csernansky CA, Choi DW Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994; 13.: 487-494
55. Pietraforte D, Tritarelli E, Testa U, Minetti M gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 1994; 55.: 175-182
56. Giulian D, Wendt E, Vaca K, Noonan CA The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A 1993; 90.: 2769-2773
57. Brenneman DE, Nicol T, Warren D, Bowers LM Vasoactive intestinal peptide.: a neurotrophic releasing agent and an astroglial mitogen. J Neurosci Res 1990; 25.: 386-394
58. Benos DJ, Hahn BH, Bubien JK, Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes.: implications for AIDS dementia complex. Proc Natl Acad Sci U S A 1994; 91.: 494-498
59. Barbour B, Szatkowski M, Ingledew N, Attwell D Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 1989; 342.: 918-920
60. Olney JW, Zorumski C, Price MT, Labruyere J L-cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science 1990; 248.: 596-599
61. Savio T, Levi G Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C.: a study with rat cerebellar granule cell cultures. J Neurosci Res 1993; 34.: 265-272
62. Lei SZ, Zhang D, Abele AE, Lipton SA Blockade of NMDA receptor-mediated mobilization or intracellular Ca+ prevents neurotoxicity. Brain Res 1992; 598.: 196-202
63. Lipton S.A. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 1992; 42.: 1403-1405
64. Muller WEG, Schroder HC, Ushijima H, Dapper J, Bormann J gp120 of HIV-1 induces apoptosis in rat cortical cell cultures.: prevention by memantine. Eur J Pharmacol 1992; 226.: 209-214
65. Lipton S.A. 7-Chlorokynurenate ameliorates neuronal injury mediated by HIV envelope protein gp120 in rodent retinal cultures. Eur J Neurosci 1992; 4.: 1411-1415
66. Lipton SA Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 1993; 33.: 227-228
67. Chen HS, Pellegrini JW, Aggarwal SK, Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine.: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12.: 4427-4436
68. Lipton SA, Jensen FE Memantine, a clinically-tolerated NMDA open-channel blocker, prevents HIV coat protein-induced neuronal injury in vitro and in vivo. Soc Neurosci 1992; 18.: 757-757 abstract.
69. Lipton S.A. Prospects for clinically tolerated NMDA antagonists.: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 1993; 16.: 527-532
70. Lipton SA, Kater SB Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci 1989; 12.: 265-270
71. Petito CK, Cash KS Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome.: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992; 32.: 658-666
72. Power L, Kong PA, Crawford TO, Cerebral white matter changes in acquired immunodeficiency syndrome.: alterations of the blood-brain barrier. Ann Neurol 1993; 34.: 339-350
73. Buzy J, Brenneman DE, Pert CB, Martin A, Salazar A, Ruff MR Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T. Brain Res 1992; 598.: 10-18
74. Gomatos PJ, Stamatos NM, Gendelman HE, Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol 1990; 144.: 4183-4188
75. Sidtis JJ, Gatsonis C, Price RW, Zidovudine treatment of the AIDS dementia complex.: results of a placebo-controlled trial. Ann Neurol 1993; 33.: 343-349